Manoj Kumar Yadav

Dr. Manoj Kumar Yadav

National Institutes of Health, Bethesda, Maryland, USA
+1
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Experimental Animals
Verified
Journal Article
Open access
PDF file
MHMichito Hamada
Michito Hamada
YTYuki Tsunakawa
Yuki Tsunakawa
HJHyojung Jeon
Hyojung Jeon
Manoj Kumar YadavManoj Kumar Yadav
Manoj Kumar Yadav
Satoru TakahashiSatoru Takahashi
Satoru Takahashi
The transcription factor MafB regulates macrophage differentiation. However, studies on the phenotype of Mafb-deficient macrophages are still limited. Recently, it was shown that the specific expression of MafB permits macrophages to be distinguished from dendritic cells. In addition, MafB has been reported to be involved in various diseases related to macrophages. Studies using macrophage-specific Mafb-deficient mice show that MafB is linked to atherosclerosis, autoimmunity, obesity, and ischemic stroke, all of which exhibit macrophage abnormality. Therefore, MafB is hypothesized to be indispensable for the regulation of macrophages to maintain systemic homeostasis and may serve as an innovative target for treating macrophage-related diseases.

1 August 2020 in Kidney International
Verified
Journal Article
Closed access
TUToshiaki Usui
Toshiaki Usui
NMNaoki Morito
Naoki Morito
HSHossam H. Shawki
Hossam H. Shawki
YSYoshinori Sato
Yoshinori Sato
HTHiroyasu Tsukaguchi
Hiroyasu Tsukaguchi
STSatoru Takahashi
Satoru Takahashi

1 April 2020 in Neuropharmacology
Verified
Journal Article
Closed access
LALokesh Agrawal
Lokesh Agrawal
MKMustafa Korkutata
Mustafa Korkutata
SVSunil Kumar Vimal
Sunil Kumar Vimal
Manoj Kumar YadavManoj Kumar Yadav
Manoj Kumar Yadav
SBSanjib Bhattacharyya
Sanjib Bhattacharyya
TSTakashi Shiga
Takashi Shiga

1 January 2020 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
Manoj Kumar YadavManoj Kumar Yadav
Manoj Kumar Yadav
YIYuri Inoue
Yuri Inoue
ANAya Nakane-Otani
Aya Nakane-Otani
YTYuki Tsunakawa
Yuki Tsunakawa
HJHyojung Jeon
Hyojung Jeon
MHMichito Hamada
Michito Hamada

1 March 2020 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
MKMaho Kanai
Maho Kanai
HJHyojung Jeon
Hyojung Jeon
MOMasami Ojima
Masami Ojima
TNTeppei Nishino
Teppei Nishino
TUToshiaki Usui
Toshiaki Usui
MHMichito Hamada
Michito Hamada

Verified
Journal Article
Open access
PDF file
OSOmar Samir
Omar Samir
NKNaohiro Kobayashi
Naohiro Kobayashi
TNTeppei Nishino
Teppei Nishino
MSMennatullah Siyam
Mennatullah Siyam
Manoj Kumar YadavManoj Kumar Yadav
Manoj Kumar Yadav
MHMichito Hamada
Michito Hamada
MAFB is a basic leucine zipper (bZIP) transcription factor specifically expressed in macrophages. We have previously identified MAFB as a candidate marker for tumor-associated macrophages (TAMs) in human and mouse models. Here, we analyzed single-cell sequencing data of patients with lung adenocarcinoma obtained from the GEO database (GSE131907). Analyzed data showed that general macrophage marker CD68 and macrophage scavenger receptor 1 (CD204) were expressed in TAM and lung tissue macrophage clusters, while transcription factor MAFB was expressed specifically in TAM clusters. Clinical records of 120 patients with lung adenocarcinoma stage I (n = 57), II (n = 21), and III (n = 42) were retrieved from Tsukuba Human Tissue Biobank Center (THB) in the University of Tsukuba Hospital, Japan. Tumor tissues from these patients were extracted and stained with anti-human MAFB antibody, and then MAFB-positive cells relative to the tissue area (MAFB+ cells/tissue area) were morphometrically quantified. Our results indicated that higher numbers of MAFB+ cells significantly correlated to increased local lymph node metastasis (nodal involvement), high recurrence rate, poor pathological stage, increased lymphatic permeation, higher vascular invasion, and pleural infiltration. Moreover, increased amounts of MAFB+ cells were related to poor overall survival and disease-free survival, especially in smokers. These data indicate that MAFB may be a suitable prognostic biomarker for smoker lung cancer patients.